CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$50.10 -0.40 (-0.79%)
As of: Oct 22, 2026 · 11:02 AM EDT

CRISPR Therapeutics AG (CRSP) Equity Income (2016 - 2019)

Updated

CRISPR Therapeutics AG's Equity Income came in at -$5.47 million for FY2019, compared with -$4.28 million in FY2018.

Analysis

CRISPR Therapeutics AG (CRSP) Equity Income (2016 - 2019) Analysis & Trends

Going back to FY2016, CRISPR Therapeutics AG's Equity Income data covers 4 years.

  • The FY2019 figure represents the lowest annual Equity Income since FY2016.
  • Per Business Quant, earlier years put Equity Income at -$4.28 million in FY2018, -$1.76 million in FY2017 and -$36.5 million in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,171.06 Bn 1,139.65 Bn 19.71 Bn -
2 Johnson & Johnson 634.89 Bn 553.42 Bn 17.26 Bn -
3 AbbVie 503.32 Bn 476.44 Bn 12.70 Bn -
4 Merck 377.44 Bn 331.82 Bn 12.21 Bn -
5 Novartis Ag 303.91 Bn 267.90 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 267.03 Bn 240.72 Bn 12.86 Bn -10.00 Mn
7 Amgen 241.88 Bn 197.28 Bn 7.24 Bn -
8 Gilead Sciences 194.01 Bn 168.20 Bn 6.22 Bn -
9 Pfizer 172.57 Bn 119.21 Bn 10.94 Bn -
10 CRISPR Therapeutics AG 4.84 Bn -3.86 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 -3.43 Mn
Jun 30, 2019 -1.01 Mn
Mar 31, 2019 -1.03 Mn
Dec 31, 2018 -1.02 Mn
Sep 30, 2018 -1.01 Mn
Jun 30, 2018 -1.15 Mn
Mar 31, 2018 -1.09 Mn
Dec 31, 2017 -453,000.00
Sep 30, 2017 -359,000.00
Jun 30, 2017 -505,000.00
Mar 31, 2017 -446,000.00
Dec 31, 2016 -35.81 Mn
Jun 30, 2016 -686,000.00
API Access

CRISPR Therapeutics AG Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=CRSP&period=max&api_key=YOUR_API_KEY